☰

Samantha J Thompson - Publications

Affiliations: 
University of Alabama, Birmingham, Birmingham, AL, United States 
 2018- Neuroscience Baylor College of Medicine, Houston, TX 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Roth JR, Rush T, Thompson SJ, Aldaher AR, Dunn TB, Mesina JS, Cochran JN, Boyle NR, Dean HB, Yang Z, Pathak V, Ruiz P, Wu M, Day JJ, Bostwick JR, et al. Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 21: e00291. PMID 38241154 DOI: 10.1016/j.neurot.2023.10.001  0.467
2022 Aloi MS, Thompson SJ, Quartapella N, Noebels JL. Loss of functional System x-c uncouples aberrant postnatal neurogenesis from epileptogenesis in the hippocampus of Kcna1-KO mice. Cell Reports. 41: 111696. PMID 36417872 DOI: 10.1016/j.celrep.2022.111696  0.402
2021 Massey CA, Thompson SJ, Ostrom RW, Drabek J, Sveinsson OA, Tomson T, Haas EA, Mena OJ, Goldman AM, Noebels JL. X-linked serotonin 2C receptor is associated with a non-canonical pathway for sudden unexpected death in epilepsy. Brain Communications. 3: fcab149. PMID 34396109 DOI: 10.1093/braincomms/fcab149  0.403
2019 Rush T, Roth JR, Thompson SJ, Aldaher AR, Cochran JN, Roberson ED. A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity. Neurobiology of Disease. 104668. PMID 31698056 DOI: 10.1016/J.Nbd.2019.104668  0.443
Show low-probability matches.